1403P - Open-label multicenter randomized phase II study of docetaxel plus bevacizumab or pemetrexed plus bevacizumab for elderly (≥75 years old) patients (pts) with previously untreated advanced non-squamous non-small cell lung cancer (NSCLC): TORG1323
| Autor: | Honda, T., Kouzuki, T., Tsunezuka, Y., Seki, N., Shibayama, T., Okimoto, T., Taniguchi, H., Takeda, Y., Hata, N., Sugimoto, K., Takahashi, N., Sakai, K., Nishimura, T., Ikeda, S., Watanabe, S., Mori, K., Shinkai, T. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|